Effect of endoscopic resection on short-term surgical outcomes of subsequent laparoscopic gastrectomy: a meta-analysis.
Endoscopic resection
Gastric cancer
Laparoscopic gastrectomy
Meta-analysis
Journal
World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544
Informations de publication
Date de publication:
14 Apr 2021
14 Apr 2021
Historique:
received:
12
10
2020
accepted:
03
04
2021
entrez:
15
4
2021
pubmed:
16
4
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Endoscopic resection (ER) might affect subsequent laparoscopic gastrectomy (LG) because of the electrical coagulation, but the effect remains controversial. The purpose of this meta-analysis was to analyze the effect of ER on the short-term surgical outcomes of subsequent LG. The PubMed, EMBASE, and Cochrane Library databases were searched to find eligible studies published from inception to March 21, 2021. Short-term surgical outcomes were compared between the ER-LG group and the LG-only group. The registration ID of this current meta-analysis on PROSPERO is CRD42021238031. Nine studies involving 3611 patients were included in this meta-analysis. The LG-only group had a higher T stage (T1-T2: OR=2.42, 95% CI=1.09 to 5.34, P=0.03; T3-T4: OR=0.41, 95% CI=0.19 to 0.91, P=0.03) than the ER-LG group. The ER-LG group showed a shorter operation time than the LG-only group (MD=-5.98, 95% CI=-10.99 to -0.97, P=0.02). However, no difference was found in operation time after subgroup analysis of propensity score matching studies. No significant difference was found in intraoperative blood loss, time to first oral feeding, or postoperative hospital stay between the ER-LG group and the LG-only group. And no significance was found in overall complications (OR=1.16, 95% CI=0.89 to 1.50, P=0.27), complications of grade ≥ II (OR=1.11, 95% CI=0.71 to 1.73, P=0.64), complications of grade ≥ III b (OR=1.47, 95% CI=0.49 to 4.43, P=0.49) between the ER-LG group and the LG-only group. ER did not affect subsequent LG in terms of short-term outcomes, and the ER-LG group might have a shorter operation time than the LG-only group.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic resection (ER) might affect subsequent laparoscopic gastrectomy (LG) because of the electrical coagulation, but the effect remains controversial. The purpose of this meta-analysis was to analyze the effect of ER on the short-term surgical outcomes of subsequent LG.
MATERIALS AND METHODS
METHODS
The PubMed, EMBASE, and Cochrane Library databases were searched to find eligible studies published from inception to March 21, 2021. Short-term surgical outcomes were compared between the ER-LG group and the LG-only group. The registration ID of this current meta-analysis on PROSPERO is CRD42021238031.
RESULTS
RESULTS
Nine studies involving 3611 patients were included in this meta-analysis. The LG-only group had a higher T stage (T1-T2: OR=2.42, 95% CI=1.09 to 5.34, P=0.03; T3-T4: OR=0.41, 95% CI=0.19 to 0.91, P=0.03) than the ER-LG group. The ER-LG group showed a shorter operation time than the LG-only group (MD=-5.98, 95% CI=-10.99 to -0.97, P=0.02). However, no difference was found in operation time after subgroup analysis of propensity score matching studies. No significant difference was found in intraoperative blood loss, time to first oral feeding, or postoperative hospital stay between the ER-LG group and the LG-only group. And no significance was found in overall complications (OR=1.16, 95% CI=0.89 to 1.50, P=0.27), complications of grade ≥ II (OR=1.11, 95% CI=0.71 to 1.73, P=0.64), complications of grade ≥ III b (OR=1.47, 95% CI=0.49 to 4.43, P=0.49) between the ER-LG group and the LG-only group.
CONCLUSIONS
CONCLUSIONS
ER did not affect subsequent LG in terms of short-term outcomes, and the ER-LG group might have a shorter operation time than the LG-only group.
Identifiants
pubmed: 33853622
doi: 10.1186/s12957-021-02230-5
pii: 10.1186/s12957-021-02230-5
pmc: PMC8048215
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
119Subventions
Organisme : Natural Science Foundation of Chongqing
ID : cstc2020jcyj-msxmX0270
Références
Gastroenterol Rep (Oxf). 2019 Apr;7(2):91-97
pubmed: 30976421
Ann Surg Oncol. 2015 Oct;22(11):3590-6
pubmed: 25631063
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Sci Rep. 2019 Dec 4;9(1):18331
pubmed: 31797969
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Surg Today. 2020 Oct;50(10):1290-1296
pubmed: 32358629
Gut. 2001 Feb;48(2):225-9
pubmed: 11156645
J Eval Clin Pract. 2008 Oct;14(5):951-7
pubmed: 19018930
Surg Endosc. 2019 Oct;33(10):3341-3354
pubmed: 30560498
Br J Surg. 2011 Mar;98(3):385-90
pubmed: 21254013
Langenbecks Arch Surg. 2015 Dec;400(8):967-72
pubmed: 26476630
Oncol Rep. 2012 Dec;28(6):2205-10
pubmed: 22993111
Gastric Cancer. 2013 Oct;16(4):549-54
pubmed: 23423491
J Gastric Cancer. 2017 Mar;17(1):33-42
pubmed: 28337361
Gastrointest Endosc. 2010 Aug;72(2):438-43
pubmed: 20541190
Surg Endosc. 2021 Mar;35(3):1202-1209
pubmed: 32152675
Surg Endosc. 2020 Nov;34(11):4983-4990
pubmed: 31820153
Gastric Cancer. 2020 Sep;23(5):913-921
pubmed: 32180055
J Gastroenterol Hepatol. 2012 Sep;27(9):1441-6
pubmed: 22497427
Ann Surg Oncol. 2020 Jan;27(1):313-320
pubmed: 31641951
Gastric Cancer. 2015 Jul;18(3):612-7
pubmed: 25098924
J Clin Oncol. 2006 May 10;24(14):2137-50
pubmed: 16682732
World J Gastroenterol. 2016 Jan 14;22(2):727-35
pubmed: 26811620
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Surg Oncol. 2017 Jun;24(6):1643-1649
pubmed: 28150166
Anticancer Res. 2013 Sep;33(9):4023-8
pubmed: 24023345
J Surg Oncol. 2012 Mar;105(3):297-303
pubmed: 21952834
Surg Laparosc Endosc. 1994 Apr;4(2):146-8
pubmed: 8180768
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Surgery. 1999 Feb;125(2):148-54
pubmed: 10026747
J Clin Oncol. 2005 Jul 10;23(20):4490-8
pubmed: 16002839
J Clin Oncol. 2020 Oct 1;38(28):3304-3313
pubmed: 32816629
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120